At the GIPR, tirzepatide triggers Gs-mediated cAMP production in adipocytes and pancreatic beta cells, enhancing insulin secretion, improving fat storage efficiency in subcutaneous depots, and increasing lipid buffering capacity
Patients are considered on a case-by-case basis
This guide explores the key differences between Tirzepatide and Retatrutide, their mechanisms in laboratory research, and why Retatrutide is considered one of the most advanced next-generation metabolic research peptides currently under investigation
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
B newsletter for a weekly report on the latest in healthcare + research-based advice for staying healthy and mentally well.
However, allow 4-6 weeks off for receptor resensitization